These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

765 related items for PubMed ID: 29602754

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.
    Cochrane Database Syst Rev; 2015 Sep 08; 2015(9):CD009938. PubMed ID: 26346232
    [Abstract] [Full Text] [Related]

  • 3. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.
    JACC Cardiovasc Interv; 2013 Dec 08; 6(12):1316-23. PubMed ID: 24139929
    [Abstract] [Full Text] [Related]

  • 4. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
    Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.
    Eur Heart J; 2013 Nov 08; 34(43):3342-52. PubMed ID: 23847132
    [Abstract] [Full Text] [Related]

  • 5. Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis.
    Wolfrum M, Froehlich GM, Knapp G, Casaubon LK, DiNicolantonio JJ, Lansky AJ, Meier P.
    Heart; 2014 Mar 08; 100(5):389-95. PubMed ID: 23793373
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM, Carroll JD.
    Circ Cardiovasc Interv; 2018 Mar 08; 11(3):e004152. PubMed ID: 29870380
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F, Al-Khadra Y, Soud M, Fanari Z, Alraies MC.
    Cerebrovasc Dis; 2018 Mar 08; 45(3-4):162-169. PubMed ID: 29597192
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous Closure Versus Medical Treatment in Stroke Patients With Patent Foramen Ovale: A Systematic Review and Meta-analysis.
    De Rosa S, Sievert H, Sabatino J, Polimeni A, Sorrentino S, Indolfi C.
    Ann Intern Med; 2018 Mar 06; 168(5):343-350. PubMed ID: 29310133
    [Abstract] [Full Text] [Related]

  • 14. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
    Fortuni F, Crimi G, Leonardi S, Angelini F, Raisaro A, Lanzarini LF, Oltrona Visconti L, Ferrario M, De Ferrari GM.
    J Cardiovasc Med (Hagerstown); 2018 Jul 06; 19(7):373-381. PubMed ID: 29708911
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.
    Pickett CA, Villines TC, Ferguson MA, Hulten EA.
    Tex Heart Inst J; 2014 Aug 06; 41(4):357-67. PubMed ID: 25120387
    [Abstract] [Full Text] [Related]

  • 16. Patent foramen ovale closure versus medical therapy after cryptogenic stroke: An updated meta-analysis of all randomized clinical trials.
    Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G.
    Cardiol J; 2019 Aug 06; 26(1):47-55. PubMed ID: 29512097
    [Abstract] [Full Text] [Related]

  • 17. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
    Lattanzi S, Brigo F, Cagnetti C, Di Napoli M, Silvestrini M.
    Cerebrovasc Dis; 2018 Aug 06; 45(5-6):193-203. PubMed ID: 29649819
    [Abstract] [Full Text] [Related]

  • 18. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
    Schulze V, Lin Y, Karathanos A, Brockmeyer M, Zeus T, Polzin A, Perings S, Kelm M, Wolff G.
    Clin Res Cardiol; 2018 Sep 06; 107(9):745-755. PubMed ID: 29500568
    [Abstract] [Full Text] [Related]

  • 19. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM, Nascimento FO, Yang SC, Kirtane AJ, Sommer RJ, Beohar N.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):968-75. PubMed ID: 23832613
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS, Lam YY, Yu CM.
    Int J Cardiol; 2013 Oct 09; 168(4):4132-8. PubMed ID: 23890879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.